Scientific Advisors



Seven Internationally Recognized Scientists Compose the Company’s Scientific Advisory Board


A Professor Emeritus of the Department of Natural Products of the School of Pharmacy at the Faculty of Medicine of the Hebrew University of Jerusalem, and a member of the Israel Academy of Sciences and Humanities. Prof. Mechoulam’s research in the field of cannabis has led to his the discovery of the endocannabi­noid system. Additionally, he was among the first to complete the total synthesis of the major plant cannabi­noids, THC, cannabidiol, cannabigerol, and others, and also played a key role in the isola­tion of the first described endocannabi­noid anandamide. Prof. Mechoulam has received amongst others, the Israel Prize in 2000, the European College of Neuropsychopharmacology Lifetime Achievement Award in 2006 and the Rothschild Prize in 2012.


Dr. Bloch, M.D., M.S. (Yale School of Medicine) is the associate training director of the Child Study Center’s Solnit Integrated Program. Dr. Bloch’s research inter­ests focus on studying TS, OCD, and trichotil­lo­mania. His current research involves devel­oping superior treat­ments for children and adults diagnosed with the afore­men­tioned indica­tions and examining predic­tors of long-term outcomes with an emphasis on neuroimaging. Dr. Bloch has has received the Keese Prize (Best Research Thesis by gradu­ating medical student at Yale University), the Lustman Award (Best Research performed by Psychiatry Resident at Yale University) and the AACAP Norbert and Charlotte Rieger Award for Scientific Achievement (Best Manuscript Published in JAACAP by Child Psychiatrist).



Prof. James Leckman, M.D. is the Neison Harris Professor of Child Psychiatry, Psychiatry, Psychology and Pediatrics at Yale University. Prof. Leckman has served as Director of Research for the Yale Child Study Center for more than twenty years. Prof. Leckman’s current research involves exploring whether the strength­ening of families and the enhance­ment of child­hood devel­op­ment leads to peaceful results and the preven­tion of violence. Additionally, Prof. Leckman has a longstanding interest in TS and OCD. Prof. Leckman is the author or co-author of over 430 original articles published in peer-reviewed journals, twelve books, and 140 book chapters.



Prof. Kirsten Müller-Vahl is a Professor of Psychiatry at the Department of Psychiatry, Socialpsychiatry and Psychotherapy at the Hanover Medical School, Germany. Prof. Müller-Vahl specialist in both neurology and adult psychi­atry and has worked exten­sively at a special­ized movement disorder clinic. For six years, Prof. Müller-Vahl was a grant-holder for the German Government for scien­tific research related to TS. Over the past eighteen years, Dr. Müller-Vahl has inves­ti­gated more than 12000 patients with TS, both children and adults, and has served as the head of the TS outpa­tient depart­ment for over twenty years. Additionally, Prof. Müller-Vahl served on the scien­tific advisory Board of the German Tourette Syndrome Association, and, in 2011, she became the presi­dent of the German Society for the Study of Tourette Syndrome. Furthermore, Prof. Müller-Vahl is a German repre­sen­ta­tive member of the manage­ment committee and coordi­nator of the COST Action BM0905, which is involved the study of TS, and the leader of Working Group 4, which is involved in outreach activ­i­ties. Prof. Müller-Vahl is a full partner in the EU funded FP7 program, the “European Multicentre Tics in Children Studies.”



Prof. Daniele Piomelli serves as the Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology, and Biological Chemistry at University of California, Irvine. Prof. Piomelli is also the founding director of the drug discovery and devel­op­ment unit (D3) at the Italian Institute of Technology in Genoa, Italy, as well as the Editor in Chief of Cannabis and Cannabinoid Research of Cannabis and Cannabinoid Research. Prof. Piomelli’s research has resulted in several contri­bu­tions to the pharma­cology of lipid based signaling molecules including endocannabi­noid substances and lipid amides. Prof. Piomelli is the author of more than 400 peer reviewed articles and books and has received several awards and honors. Prof. Piomelli studied Pharmacology and Neuroscience at Columbia University, and the Rockefeller University, and earned his degree of Doctor of Pharmacy from University of Naples.



Prof. Michael Davidson currently serves, among other things, as Chairman of the Stuckinski Centre for Alzheimer’s Disease Research in Ramat Gan. Prof. Davidson is also the editor of European Neuropsychopharmacology. Prof. Davidson served as Chief Psychiatrist at the Department of Psychiatry of the Sheba Medical Centre in Tel-Hashomer for six years. Prof. Davidson holds a profes­sor­ship at the Sackler School of Medicine of Tel Aviv University and a secondary appoint­ment at the Mount Sinai School of Medicine in New York. Prof. Davidson is consid­ered an inter­na­tional expert on Alzheimer’s and is the author of approx­i­mately 300 publi­ca­tions in scien­tific liter­a­ture.



Prof. Avi Weizman is a Professor of Child and Adult Psychiatry at the Sackler Faculty of Medicine of Tel Aviv University, a Director of the Felsentein Medical Research Center and the head of a Laboratory for Biological Psychiatry and the head of a Research Unit at the Geha Mental Health Center. Prof. Weizman’s research involves the inves­ti­ga­tion of brain mecha­nisms of mental disor­ders, and currently focuses on neurode­vel­op­mental disor­ders, devel­op­ment of new strate­gies for the treat­ment of psychotic disor­ders and the psychophar­ma­cology of mental disor­ders.